3/6
08:03 am
clym
Climb Bio (CLYM) had its price target raised by Robert W. Baird from $9.00 to $12.00. They now have an "outperform" rating on the stock.
Medium
Report
Climb Bio (CLYM) had its price target raised by Robert W. Baird from $9.00 to $12.00. They now have an "outperform" rating on the stock.
3/5
08:45 am
clym
Climb Bio (CLYM) is now covered by Wedbush. They set an "outperform" rating and a $12.00 price target on the stock.
Low
Report
Climb Bio (CLYM) is now covered by Wedbush. They set an "outperform" rating and a $12.00 price target on the stock.
3/5
07:15 am
clym
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates [Yahoo! Finance]
Medium
Report
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates [Yahoo! Finance]
3/5
07:00 am
clym
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
Low
Report
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
2/13
07:01 am
clym
Climb Bio (NASDAQ:CLYM) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
Low
Report
Climb Bio (NASDAQ:CLYM) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
2/5
07:18 am
clym
Climb Bio to Present at Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Climb Bio to Present at Upcoming Investor Conferences [Yahoo! Finance]
2/5
07:00 am
clym
Climb Bio to Present at Upcoming Investor Conferences
Medium
Report
Climb Bio to Present at Upcoming Investor Conferences
1/24
07:11 pm
clym
Climb Bio, Inc. (NASDAQ:CLYM) Shares Could Be 45% Below Their Intrinsic Value Estimate [Yahoo! Finance]
Low
Report
Climb Bio, Inc. (NASDAQ:CLYM) Shares Could Be 45% Below Their Intrinsic Value Estimate [Yahoo! Finance]
1/8
07:00 am
clym
Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026
Medium
Report
Climb Bio Announces Pipeline Progress and Strategic Priorities for 2026
12/31
11:21 am
clym
H.C. Wainwright Forecasts 2026 Data Readouts for Climb Bio's (CLYM) Budoprutug Across Clinical Tracks [Yahoo! Finance]
Neutral
Report
H.C. Wainwright Forecasts 2026 Data Readouts for Climb Bio's (CLYM) Budoprutug Across Clinical Tracks [Yahoo! Finance]
12/28
04:01 pm
clym
Here's Why We're Watching Climb Bio's (NASDAQ:CLYM) Cash Burn Situation [Yahoo! Finance]
Medium
Report
Here's Why We're Watching Climb Bio's (NASDAQ:CLYM) Cash Burn Situation [Yahoo! Finance]
12/18
07:11 am
clym
Climb Bio (NASDAQ:CLYM) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Medium
Report
Climb Bio (NASDAQ:CLYM) had its "buy" rating reaffirmed by analysts at HC Wainwright.